Constant Therapy Health, a pioneer in clinically proven AI-driven speech, language, and cognitive therapy enhances its ...

At Tryg's annual general meeting on 26 March 2025, it was decided to cancel repurchased shares from the Group's share buyback ...

Stallion Uranium Corp. (the " Company ” or " Stallion ”) ( TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce the ...

ORLANDO, Fla., April 30, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth ...

Presentation Title: GT-02287, A Clinical-stage Allosteric GCase Modulator For The Treatment Of Parkinson's Disease, Protects Dopaminergic Neurons Against Mitochondrial Toxin MPP+ Presenter: Joanne ...

Phase 2 data featured in an oral presentation at the American Academy of Neurology Annual Meeting ATH434-202 open-label trial in advanced MSA completed in March 2025 Cash balance on 31 March 2025 of ...

Cielo announces that the Meeting, which was previously set for June 10, 2025, will now be held on June 24, 2025, at which, among other things, incumbent directors of the Company, being Mr. Ryan ...

This installation marks significant progress in addressing the challenges of EV charging in robotic facilities, where traditional plug-in methods are impractical. The system enables EV owners to ...

According to UgoWork CEO Philippe Beauchamp, Lavigueur brings a 360° vision of scale, structure and impact: "Jean Lavigueur's ...

Positive delayed-type hypersensitivity (DTH) (p = 0.001) and a favorable Neutrophil-to-Lymphocyte Ratio (NLR) (p = 0.02) ...

Preclinical data demonstrates unique binding location of CT-95 on mesothelin and avoidance of binding to shed mesothelin .

"We completed the Touchstone system conversion during the first quarter of 2025 and are looking forward to building upon this ...